Immatics Biotechnologies GmbH - Company Profile
Powered by 
All the data and insights you need on Immatics Biotechnologies GmbH in one report.
$295
- Save hours of research time and resources with
our up-to-date Immatics Biotechnologies GmbH Strategy Report
- Understand Immatics Biotechnologies GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Immatics Biotechnologies GmbH Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Immatics Biotechnologies GmbH Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 29 Aug 2018 | Lorem |
| Immatics works with CRO Advanced Clinical for cell therapy candidates, CEO says | 31 Jul 2018 | Krystnell Storr |
| Immatics seeks mid-large pharma partner to fund T-cell receptor oncology discovery programmes - executive | 19 May 2016 | Fiona Barry |
| Immatics’ IMA901 kidney cancer strategy triggers mixed reviews if Phase III IMPRINT trial fails - oncologists | 21 Nov 2014 | Kathleen Raven |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer